Evidence map›Paper›PMID 39035661›Full record

ArticleJSES international2024

Two-year follow-up of the SMR stemless platform shoulder system: a multicenter, prospective clinical study.

Joost I P Willems, Gijs Achten, Mark A A Crowther, Roderich Heikenfeld, Anne Karelse, Arthur van Noort

Abstract read
In one paragraph

Article in JSES international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Mid-term clinical and radiographic outcomes at minimum five-year follow-up after stemless reverse shoulder arthroplasty.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joost I P WillemsOrthopaedic Department, Medische Kliniek Velsen, Velsen Noord, the Netherlands.
Gijs AchtenOrthopaedic Department, Spaarne Gasthuis, Hoofddorp, the Netherlands.
Mark A A CrowtherOrthopaedic Department, North Bristol NHS Trust, Bristol, United Kingdom.
Roderich HeikenfeldShoulder, Elbow and Hand Centre St. Anna Hospital, Herne, Germany.
Anne KarelseOrthopaedic Department, ZorgSaam Hospital, Terneuzen, the Netherlands.
Arthur van NoortOrthopaedic Department, Spaarne Gasthuis, Hoofddorp, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of stemless shoulder arthroplasty for osteoarthritis has grown substantially over the past decades. The goal of this study is to evaluate the clinical and radiological outcomes of the Lima SMR stemless anatomic and reverse total shoulder arthroplasty. Methods: Seventy-three implants in 73 patients (61 anatomic total shoulder arthroplasties [aTSAs] and 12 reverse shoulder arthroplasties [RSAs]) were analyzed with a minimum follow-up of 2 years. The average age in the aTSA group was 65.8 ± 8.7 and 78.3 ± 4.8 in the RSA group. Primary osteoarthritis was the indication in most cases (aTSA 93.7%, RSA 67%). Patients were evaluated preoperatively, at 4, 12, and 24 months postoperatively using the Constant score, the ASES, Oxford Shoulder Score, EuroQol 5 Dimensions 5 Levels questionnaire, range of motion scores, and radiographically. Statistical significance was evaluated using the paired Results: At 2-year follow-up, the overall average Constant score significantly improved from 40.0 ± 16.7 to 80.9 ± 21.4 ( Conclusion: The 2-year results presented in this study show good functional and radiological outcomes using the SMR stemless system.

Indexed as

ComplicationsOutcomesProspective case seriesShoulder arthroplastyStemless anatomic total shoulderStemless reverse total shoulder

Identifiers

PMID39035661
PMCPMC11258836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.